Catechol-O-methyltransferase val158met genotype determines effect of reboxetine on emotional memory in healthy male volunteers
Author(s) -
Ayana A. Gibbs,
Carla E. Bautista,
Florence D. Mowlem,
Kris Naudts,
Dora Duka
Publication year - 2014
Publication title -
journal of psychiatry and neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.767
H-Index - 99
eISSN - 1488-2434
pISSN - 1180-4882
DOI - 10.1503/jpn.130131
Subject(s) - reboxetine , catechol o methyl transferase , placebo , psychology , cognition , clinical psychology , antidepressant , medicine , psychiatry , allele , reuptake inhibitor , anxiety , biochemistry , chemistry , alternative medicine , pathology , gene
Catechol-O-methyltransferase (COMT) metabolizes catecholamines in the prefrontal cortex (PFC). A common polymorphism in the COMT gene (COMT val158met) has pleiotropic effects on cognitive and emotional processing. The met allele has been associated with enhanced cognitive processing but impaired emotional processing relative to the val allele.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom